Dr. Mohamed Kanaa, MD

NPI: 1215932496
Total Payments
$1,282
2023 Payments
$12.80
Companies
18
Transactions
81

Payment Breakdown by Category

Food & Beverage$1,170 (91.3%)
Education$111.80 (8.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,170 79 91.3%
Education $111.80 2 8.7%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $339.39 20 $0 (2019)
Genentech USA, Inc. $235.96 17 $0 (2018)
PFIZER INC. $189.93 16 $0 (2023)
Shire North American Group Inc $99.00 1 $0 (2017)
E.R. Squibb & Sons, L.L.C. $73.33 6 $0 (2017)
Merck Sharp & Dohme Corporation $58.89 4 $0 (2017)
Dendreon Pharmaceuticals LLC $43.32 2 $0 (2017)
Teva Pharmaceuticals USA, Inc. $38.29 2 $0 (2017)
Foundation Medicine, Inc. $31.24 2 $0 (2018)
Pharmacyclics LLC, An AbbVie Company $28.82 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $12.80 1 PFIZER INC. ($12.80)
2020 $12.49 1 PFIZER INC. ($12.49)
2019 $139.89 6 Novartis Pharmaceuticals Corporation ($139.89)
2018 $59.58 4 PFIZER INC. ($26.23)
2017 $1,057 69 Genentech USA, Inc. ($222.29)

All Payment Transactions

81 individual payment records from CMS Open Payments — Page 4 of 4

Date Company Product Nature Form Amount Type
02/14/2017 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $15.09 General
Category: ONCOLOGY
02/09/2017 Novartis Pharmaceuticals Corporation TASIGNA (Drug) Food and Beverage In-kind items and services $22.80 General
Category: ONCOLOGY
02/01/2017 Teva Pharmaceuticals USA, Inc. BENDEKA (Drug) Food and Beverage In-kind items and services $17.25 General
Category: Oncology
01/17/2017 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $16.69 General
Category: Oncology
01/04/2017 Genentech USA, Inc. VENCLEXTA (Biological) Food and Beverage In-kind items and services $14.63 General
Category: BioOncology
01/03/2017 Bayer HealthCare Pharmaceuticals Inc. Stivarga (Drug), Nexavar Food and Beverage In-kind items and services $15.78 General
Category: Oncology

About Dr. Mohamed Kanaa, MD

Dr. Mohamed Kanaa, MD is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215932496.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Kanaa, MD has received a total of $1,282 in payments from pharmaceutical and medical device companies, with $12.80 received in 2023. These payments were reported across 81 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,170).

Practice Information

  • Specialty Hematology & Oncology
  • Location Oklahoma City, OK
  • Active Since 06/15/2005
  • Last Updated 07/08/2007
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1215932496

Products in Payments

  • XIIDRA (Drug) $139.89
  • ELAPRASE (Biological) $99.00
  • IBRANCE (Drug) $79.84
  • VENCLEXTA (Biological) $67.73
  • MEKINIST (Drug) $64.71
  • OPDIVO (Biological) $62.33
  • Perjeta (Biological) $62.04
  • TECENTRIQ (Biological) $56.36
  • PROVENGE (Drug) $43.32
  • SANDOSTATIN LAR (Drug) $41.08
  • KEYTRUDA (Biological) $40.89
  • AFINITOR (Drug) $40.73
  • TASIGNA (Drug) $39.77
  • BENDEKA (Drug) $38.29
  • FOUNDATIONONE (Device) $31.24
  • Imbruvica (Drug) $28.82
  • XTANDI (Drug) $28.31
  • ELIQUIS (Drug) $25.43
  • SUTENT (Drug) $24.56
  • CHANTIX (Drug) $23.57

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Oklahoma City